Site Map

• SC Start Form

• IV Start Form

• Home

• PsA Efficacy

  PsA Efficacy

  • Manifestations
  • Radiographic Change
  • Disease Activity and Function

• AS Efficacy

  AS Efficacy

  • Hallmarks of Disease
  • Disease Activity
  • Inflammation

• nr-axSpA Efficacy

  nr-axSpA Efficacy

  • Hallmarks of Disease
  • Disease Activity
  • Inflammation

• JPsA/ERA Efficacy

• Safety and Experience

  Safety and Experience

  • PsA Safety
  • AS Safety
  • nr-axSpA Safety
  • Experience​​

• Dosing and Devices​

  Dosing and Devices​

  • SC Dosing
  • Devices and Injection Videos
  • IV Dosing

• Local Insurance Coverage Tool​

• Novartis Patient Support

• Resources

  Resources

  • SC Resources
  • IV Resources

• MOA​

• SC Start Form

• Home

• Disease Characteristics

  Disease Characteristics

  • Hidradenitis Suppurativa (HS)​
  • Plaque Psoriasis (PsO)​

• HS Efficacy

  HS Efficacy

  • Start Early
  • Lasting Impact

• Pediatric HS

• PsO Efficacy

  PsO Efficacy

  • PsO Start With Skin​
  • PsA: Protect Within

• Pediatric PsO Efficacy

• Safety

  Safety

  • HS Safety​​
  • PsO Adult Safety​
  • PsO Pediatric Safety​​
  • Experience

• Dosing and Devices​

  Dosing and Devices​

  • HS Adult and Pediatric Dosing
  • PsO Adult and Pediatric Dosing
  • Devices and Injection Videos

• Local Insurance Coverage Tool​

• Novartis Patient Support

• Resources

  Resources

  • SC Resources

• MOA​

• SC Start Form

• IV Start Form

• Home

• Local insurance coverage

• Dermatology Home

• Rheumatology Home

• Experience

• Devices and Injection Videos

• Local Insurance Coverage Tool

• SC Resources

• MOA